Company intelligence / Profile preview

MIAS Pharma Limited

Ownership: Private
Employees: ~28
Development stage: Commercial

Overview

MIAS Pharma enables pharmaceutical and biopharma companies to import and batch release human medicinal products into the EU/EEA and UK markets by providing licensing frameworks, Qualified Person (QP) services, regulatory compliance oversight, and support as a Market Authorisation Holder. The company does not have its own drug pipeline but acts as a key partner for market entry and compliance.

Modalities: Human medicinal products (general, not specific to small molecules, biologics, etc.)
Industry: Consulting

Partnerships

No major pharma/biotech partnerships publicly listed; works with multiple small-to-medium pharma/biopharma clients entering the EU market.

Beyond the preview

Go deeper on MIAS Pharma Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIAS Pharma Limited.

Explore the full profile